Hydrops fetalis is the most deadly complication of parvovirus in pregnancy. This case shows the devastating consequences of the parvovirus infection in a second-trimester fetus and is a valuable reminder that the human parvo B19 virus is an ever-present danger to the fetus.
The prenatal detection of fetal hydrops is an alarming event for the sonologist, sonographer, and patient. A detailed anatomic survey of the fetus and the evaluation of the intrauterine environment may determine the etiology of the hydrops. Accurate antenatal diagnosis is critical for counseling the patient and her family on the potential outcome and possible choices of intervention. When fetal hydrops is identified, the mother should have TORCH studies, including parvo B19. The Rh type of the mother must be established. The antibody values must be known to determine whether the mother has formed antibodies and, if so, which antibodies she has formed. This case is a valuable reminder that the human parvo B19 virus may have a profound effect on fetal well-being. This case shows the progression of hydrops fetalis and subsequent fetal demise in a documented parvovirus infection.
Case Presentation
A 30-year-old woman, gravida 2, para 1, was referred to our office for a high-risk ultrasound examination because of a low maternal serum alpha fetoprotein (MSAFP) value. Her risk for Down syndrome was 1:160. An 11-week ultrasound examination done elsewhere had established the gestational age to be consistent with her last menstrual period. A note was made on that examination report of a "small subchorionic hemorrhage."
An ultrasound examination was performed in our institution using a 5-MHz curvilinear transducer (ATL HDI 5000) and revealed an 18-week, 4-day male fetus with appropriate interval growth. Fetal motion was noted. A small pericardial effusion and slightly enlarged heart were seen. The heart had the appropriate axis, rate, and rhythm, and no structural abnormalities were noted. There was moderate to severe ascites extending to the level of the diaphragm (Figs. 1, 2, and 3). A small amount of scalp edema was seen ( Fig. 4 ). The intra-abdominal organs were within normal limits, and no areas of increased echogenicity were noted. Also noted was a thickened bladder wall and the fact that the amniotic fluid index was subjectively increased. The placenta was unremarkable. No structural abnormalities were noted in a detailed anatomic survey. TORCH titers, atypical antibody profile, and parvovirus ab titers were ordered on the mother.
The parvovirus titer was the only positive finding. The IgM was 3.15 and the IgG was 17.0 (normal IgM is negative, and normal IgG < 10.0).
The patient returned for a follow-up scan 5 days later at a gestational age of 19 weeks, 2 days. The fetus showed increasing hydropic changes ( Fig. 5 ). There was still only a small amount of scalp edema noted ( Fig. 6 ). A cordocentesis was discussed along with the risks of transfusion. A follow-up visit was scheduled.
The patient returned at gestational age 20 weeks, 2 days for evaluation of hydrops and possible cordocentesis. No fetal heart motion was seen. There was increased scalp edema and mild cranial bone overlap. No somatic growth was demonstrated during the 2-week interval. The patient declined both autopsy and genetic testing. She was referred to labor and delivery for an induction for intrauterine fetal death.
Discussion
Parvovirus, also known as 5th disease or erythema infectiosum, is caused by parvovirus B19. It is a single-strand DNA virus that is cytoxic for erythroid progenitor cells. It was discovered in 1975 and was first linked to human disease in 1981. 1 Parvovirus B19 is most commonly transmitted among humans via respiratory secretions and hand-to-mouth contact within the first 5 to 10 days of exposure when the infection is the most contagious. Clinical infection is most common in childhood, with only 20% of clinical infections occurring in adults. Brown and colleagues 2 first reported adverse perinatal outcomes associated with maternal parvovirus infection in 1984. Since then, at least 400 cases of B19 infection have been described during pregnancy. 1 In a series of 618 pregnant women exposed to parvovirus, only 311 (50.3%) were susceptible to infection as evidenced by lack of antibody. Of those susceptible, only 52 contracted parvovirus. None of the 52 infants exposed to maternal parvovirus developed hydrops fetalis. 3 The transplacental viral transmission rate is approximately 30%. 2, 4 There is a 10% risk of spontaneous abortion occurring in the first trimester as a result of maternal infection. The overall fetal loss rate associated with maternal parvovirus infection is 2% to 10%. B19 can cause asymptomatic infection and has been associated with 5 distinct clinical syndromes: erythema infectiosum, acute arthritis in adults, transient aplastic crisis in patients with sickle cell disease or other chronic hemolytic states, chronic anemia in immunodeficient patients, and fetal hydrops. 1 Making the diagnosis can be difficult as 50% to 70% of infected adults have none of the signs or symptoms. 4 The diagnosis is confirmed by the presence of parvovirus B19 IgM and IgG antibodies in maternal serum. 5 The IgG is present 3 weeks after exposure and may persist for years. Once immune, immunity is lifelong. Individuals at high risk for infection are those who deal directly with children, such as schoolteachers, day care center workers, and personnel in a pediatric ward. Most infections, however, seem to be the result of exposure to the women's own children. 6 In pregnancy, the most deadly complication of parvovirus is hydrops fetalis. The parvovirus can cause fetal anemia by hindering erythropoiesis. 2 This makes the fetus particularly vulnerable because its red cell survival is short and its red cell volume is rapidly expanding. The resulting severe anemia causes highoutput cardiac failure followed by generalized edema. Gestational age at the time of infection seems to be the critical factor. The highest risk for the fetus seems to be between 14 and 24 weeks gestation after the increase of erythropoiesis during the second trimester. 7 Nonimmune fetal hydrops develops in 3% of pregnancies complicated by parvovirus. 2 Signs of hydrops fetalis are edematous fetal skin, scalp edema, ascites, hepatoslenomegaly, cardiomegaly, pleural effusion, and pericardial effusion.
It has been suggested in preliminary studies that the MSAFP value can be elevated with an affected fetus. 1 It is interesting to note that in this case, the MSAFP value was low. Ultrasonography continues to be the mainstay for diagnosing the effects of fetal parvovirus infection. 8 In this case, worsening subcutaneous edema, abdominal ascites, and pericardial effusion were findings consistent with those reported in the literature.
